Company profile · Biotech & medical
NaviFUS
浩宇生醫股份有限公司 · 6872
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
NaviFUS develops focused ultrasound systems and tracking systems.[1]
The company's products utilize ultrasound energy to noninvasively open the blood-brain barrier and perform neuromodulation for the treatment of brain tumors and epilepsy.[2]
NaviFUS also leases research-use systems and undertakes preclinical contract research projects.[3]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$1m | -19.0% | -30.8% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | NaviFUS Corporation |
|---|---|
| Chinese name | 浩宇生醫股份有限公司 |
| Stock code | 6872 (TPEx) |
| Industry | Biotech & medical |
| Founded | 12 Mar 2015 |
| Listed | 07 Mar 2025 |
| Paid-in capital | NT$708m |
| Chairman | 龍震宇 |
| President | 龍震宇 |
| Headquarters | 16F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 103, Taiwan(R.O.C.) |
| Website | https://navifus.com/ |
| Official business description | 「聚焦式超音波系統」及「治療導引追蹤系統」之開發 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 浩宇生醫股份有限公司 · mops · retrieved 04 Nov 2026
- NaviFUS - Non-Invasive FUS Treatment for CNS Diseases · website · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list